Joseph M. Unger, PhD (IMAGE)

SWOG Cancer Research Network

Joseph M. Unger, PhD

Caption

Joseph M. Unger, PhD, a SWOG health services researcher and biostatistician with Fred Hutchinson Cancer Center, led a secondary analysis of data from the SWOG S1404 trial in melanoma that found patients on pembrolizumab reported higher quality of life than those on standard immunotherapy.

Credit

SWOG Cancer Research Network/The Hope Foundation for Cancer Research

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.